Descovy Tablet
Product Images NDC 61958-2005

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Descovy (NDC 61958-2005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Descovy 01)

Chemical Structure (Descovy 01)
Chemical structure diagram of the active ingredient emtricitabine, showing its molecular framework including nitrogen, oxygen, fluorine, carbon, hydrogen, and sulfur atoms arranged to form the compound.*
FDA Label Image

Chemical Structure (Descovy 02)

Chemical Structure (Descovy 02)
Chemical structure of emtricitabine and tenofovir alafenamide, the active ingredients in DESCOVY tablets. The diagram shows the molecular arrangement including the phosphate group and associated components.*
FDA Label Image

Descovy-03.jpg (Descovy 03)

Descovy-03.jpg (Descovy 03)
Label for Descovy tablets containing 200 mg emtricitabine and 25 mg tenofovir alafenamide per tablet. The label indicates a 30-tablet package, oral tablet dosage form, and is manufactured for Gilead Sciences, Inc. It includes storage instructions, a pharmacist note, and a safety alert regarding medicine interactions.*
FDA Label Image

Descovy-04.jpg (Descovy 04)

Descovy-04.jpg (Descovy 04)
Descovy 200 mg/25 mg tablets packaging label showing the proprietary name and active ingredients emtricitabine and tenofovir alafenamide. The label indicates a 30 tablet blister pack, with usage instructions for pharmacists and storage information. Manufactured by Gilead Sciences, Inc., the label also includes contact information for cost or access questions.*
FDA Label Image

Descovy 05

Descovy 05
Descovy 120 mg/15 mg tablets contain emtricitabine and tenofovir alafenamide oral tablets. The label specifies the dosage strength and includes storage instructions, manufacturer Gilead Sciences, Inc., and a caution note to keep out of children's reach. The package quantity is 30 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.